• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smith & Nephew deals topical anesthetic gel to Alliance Pharma

December 1, 2017 By Sarah Faulkner

Alliance PharmaAlliance Pharma (LON:APH) has acquired the rights to Smith & Nephew‘s (NYSE:SNN) anesthetic gel Ametop for $7.5 million, according to the specialty pharmaceutical company.

The product, which Smith & Nephew has been selling in the U.K., Ireland, New Zealand and Canada for at least 10 years, is designed to numb a patient’s skin before an injection.

From Oct. 2016 to Oct. 2017, Smith & Nephew reeled in $2.8 million in sales for the product, mostly from the U.K. and Ireland.

The deal is being funded from existing cash and bank facilities, according to Alliance. The pharma company will acquire rights to Ametop, as well as inventory valued at $0.4 million.

“We are delighted to acquire Ametop, an attractive and established brand,” Alliance CEO John Dawson said in prepared remarks. “The acquisition will be immediately earnings enhancing, accretive to our underlying return on invested capital, and it fits well in our existing bedrock business operations.”

“The product is expected to add 2% to Alliance’s sales footprint in FY18E and while we make no changes to our forecasts at this stage, we could anticipate low single-digit earnings up-tick from the deal from FY18E onwards,” Numis Securities analysts wrote in a note to clients, Proactive Investors reported.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Mergers & Acquisitions, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: alliancepharma, smith&nephew

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS